Transpire Bio Inc. | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

45,538 results for “Transpire Bio Inc.”

Trials

View all 13790 →

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

2,000 participants · First posted Sep 23, 2019

Healthetech, Inc. SMART Study

56 participants · First posted Sep 19, 2005

Bioequivalence Study of Flibanserin From AphroFemine 100 mg F.C.T (Bio Med for Pharmaceuticals Industries (BIOMED), Egypt) Versus Addyi 100 mg Tablets (Sprout Pharmaceuticals, Inc., USA)

26 participants · First posted Jul 31, 2020

Drugs

View all 2572 →

Oncology inhaler(Transpire)

NeuLiv

CNS inhaler 1(Transpire)

Organizations

View all 6339 →

Belite Bio, Inc.

United States

DAEWOONG BIO INC.

South Korea

Q32 Bio Inc

United States

News

View all 22837 →

Transpire Bio Licenses PDE4 Inhibitor ITG-1052 for Idiopathic Pulmonary Fibrosis Treatment

Transpire Bio Achieves FDA Filing Acceptance for Generic High-Strength Trelegy Ellipta with Potential 180-Day Market Exclusivity

Transpire Bio Achieves FDA Filing Acceptance for Generic Breo Ellipta, Positioning for Market Exclusivity

Page 1 of 4554